247 related articles for article (PubMed ID: 2371517)
1. [Fulminant and subfulminant viral hepatitis].
Bernuau J
Rev Prat; 1990 Jun; 40(18):1652-5. PubMed ID: 2371517
[TBL] [Abstract][Full Text] [Related]
2. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.
Acharya SK; Dasarathy S; Kumer TL; Sushma S; Prasanna KS; Tandon A; Sreenivas V; Nijhawan S; Panda SK; Nanda SK; Irshad M; Joshi YK; Duttagupta S; Tandon RK; Tandon BN
Hepatology; 1996 Jun; 23(6):1448-55. PubMed ID: 8675163
[TBL] [Abstract][Full Text] [Related]
3. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.
Péron JM; Bureau C; Poirson H; Mansuy JM; Alric L; Selves J; Dupuis E; Izopet J; Vinel JP
J Viral Hepat; 2007 May; 14(5):298-303. PubMed ID: 17439518
[TBL] [Abstract][Full Text] [Related]
4. Fulminant hepatic failure: etiology, viral markers and outcome.
Bendre SV; Bavdekar AR; Bhave SA; Pandit AN; Chitambar SD; Arankalle VA
Indian Pediatr; 1999 Nov; 36(11):1107-12. PubMed ID: 10745331
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis A to E: symptoms, clinical aspects, prognosis].
Maier KP
Schweiz Rundsch Med Prax; 1992 Jun; 81(24):791-2. PubMed ID: 1604095
[TBL] [Abstract][Full Text] [Related]
6. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
[TBL] [Abstract][Full Text] [Related]
7. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
Durand F; Bernuau J; Pessayre D; Samuel D; Belaiche J; Degott C; Bismuth H; Belghiti J; Erlinger S; Rueff B
Hepatology; 1995 Apr; 21(4):929-32. PubMed ID: 7705802
[TBL] [Abstract][Full Text] [Related]
8. Serum and urinary methionine concentrations in severe hepatic failure of viral hepatitis. Relevance to development of encephalopathy and prognosis.
Kaldor J; Spelman DW; Metcalf WR; Lucas CR
Med J Aust; 1986 Jul; 145(2):76-9. PubMed ID: 3736469
[TBL] [Abstract][Full Text] [Related]
9. Fulminant viral hepatitis.
Pappas SC
Gastroenterol Clin North Am; 1995 Mar; 24(1):161-73. PubMed ID: 7729859
[TBL] [Abstract][Full Text] [Related]
10. Viral and clinical factors associated with the fulminant course of hepatitis A infection.
Rezende G; Roque-Afonso AM; Samuel D; Gigou M; Nicand E; Ferre V; Dussaix E; Bismuth H; Féray C
Hepatology; 2003 Sep; 38(3):613-8. PubMed ID: 12939587
[TBL] [Abstract][Full Text] [Related]
11. [Fulminant viral hepatitis in pregnancy: the effect of extra-corporeal assistance; role of the fetal liver (author's transl)].
Regensberg M; Denis J; Poupon R; Darnis F; Opolon P
Gastroenterol Clin Biol; 1979 Jan; 3(1):7-14. PubMed ID: 437402
[No Abstract] [Full Text] [Related]
12. A case of non A, non B, non C hepatitis that relapsed into fulminant hepatic failure.
Cuffari C; Brochu P; Russo P; Alvarez F
Hepatogastroenterology; 1998; 45(24):2348-51. PubMed ID: 9951921
[TBL] [Abstract][Full Text] [Related]
13. [Subfulminant hepatitis A treated by hepatic transplant].
Devictor D; Houssin D; Wood C; Oriot D; Mathey C; Debray D; Duval-Arnould M; Huault G
Arch Fr Pediatr; 1988; 45(6):405-7. PubMed ID: 3064730
[TBL] [Abstract][Full Text] [Related]
14. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
[TBL] [Abstract][Full Text] [Related]
15. [Morbidity and mortality associated with chronic viral hepatopathy in patients infected with the human immunodeficiency virus].
Soriano V; García-Samaniego J; Bravo R; Valencia E; Laguna F; de Pouplana M; Iñíguez A; Muñoz F; González-Lahoz J
Med Clin (Barc); 1995 May; 104(17):641-4. PubMed ID: 7623489
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis.
Shiota G; Oyama K; Noguchi N; Takano Y; Kitaoka S; Kawasaki H
Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):3-12. PubMed ID: 9755839
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.
Sinclair SB; Greig PD; Blendis LM; Abecassis M; Roberts EA; Phillips MJ; Cameron R; Levy GA
J Clin Invest; 1989 Oct; 84(4):1063-9. PubMed ID: 2794044
[TBL] [Abstract][Full Text] [Related]
18. Interferon treatment in acute progressive and fulminant hepatitis.
Levin S; Leibowitz E; Torten J; Hahn T
Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
[TBL] [Abstract][Full Text] [Related]
19. [Visual P300 in acute hepatic encephalopathy resulting from non-A-non-B fulminant hepatitis: analysis of the course before and after orthotopic liver transplantation].
Kügler CF; Taghavy A; Fleig WE; Hahn EG
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Dec; 22(4):259-63. PubMed ID: 1786789
[TBL] [Abstract][Full Text] [Related]
20. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
